Shares of
Bristol-Myers and
The three generic-drug makers can’t launch their copycat versions of Eliquis until 2031, said Susan Francis, a spokesperson for Bristol-Myers. Based on settlement agreements previously reached ...
Shares of
Bristol-Myers and
The three generic-drug makers can’t launch their copycat versions of Eliquis until 2031, said Susan Francis, a spokesperson for Bristol-Myers. Based on settlement agreements previously reached ...